BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
BriaCell Therapeutics Corp. a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce the results of its annual general and special meeting of shareholders of the Company for the years ended July 31, 2019 and July 31, 2020 held on May 18, 2021 . A total of 1,685,180 common shares of the Company were voted, representing 22.36% of the Company’s …
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”) a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce the results of its annual general and special meeting of shareholders of the Company (the ” Shareholders “) for the years ended July 31, 2019 and July 31, 2020 held on May 18, 2021 (the ” Meeting “). A total of 1,685,180 common shares of the Company (the ” Common Shares “) were voted, representing 22.36% of the Company’s issued and outstanding Common Shares. At the Meeting, the Shareholders overwhelmingly voted in favour of all proposed resolutions that consisted of the following:

Related Keywords

Martin Schmieg ,Richard Berman ,Rebecca Taub ,Vaughnc Embro Pantalony ,Charles Wiseman ,Williamv Williams ,Jules Abraham ,Jamieson Bondarenko ,Company The Shareholders ,Company Contact ,Company The Common ,Ratification Of The Company ,Nasdaq ,Briacell Therapeutics Corp ,Renewal Of The Company ,Venture Exchange ,Regulation Services Provider ,Briacell Therapeutics ,Public Relations ,ரிச்சர்ட் பெர்மன் ,ரிபேக்க த்ொஉப் ,சார்லஸ் புத்திசாலி ,நிறுவனம் தி பங்குதாரர்கள் ,நிறுவனம் தொடர்பு ,நிறுவனம் தி பொதுவானது ,நாஸ்டாக் ,பிரையசெல் சிகிச்சை கார்ப் ,துணிகர பரிமாற்றம் ,ஒழுங்குமுறை சேவைகள் வழங்குநர் ,பிரையசெல் சிகிச்சை ,பொது உறவுகள் ,